Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable
Recruiting · NCT07430956 · Registry updated 2026-09-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable | Arrhythmias, Cardiac, Embolism, Embolism and Thrombosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Thromboembolism, atrial fibrillation, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, heart disorder, ischemic stroke, lung disorder, nervous system disorder, pulmonary embolism, respiratory system disorder, stroke disorder, thrombotic disease, vascular disorder, venous thromboembolism | Recruiting | Phase 3 | 2026-09-17 | NCT07430956 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Regeneron Pharmaceuticals | 238 |
34 results · Page 1 of 2
Research sites
Swipe the table sideways for more columns.